In Taiwan, only about 15 percent of PhD researchers are hired by private companies. Therefore, we must change our business infrastructure and focus on innovation moving…
In Conversation
In 2014, my first angel investor actually told me, "91 percent of these kinds of research programs fail. I am not investing in SIMR because I…
Our optical space location technology is starting to be used in motion capture systems, which are used not only in medicine but also in many other…
Our vision is to help as many people as possible and the next stage in our development as a company is in AI and precision diagnosis.
When dealing with medical devices, although price may be important, quality is the key factor as the products are used on the human body.
BioGaia never launches a product that has not been clinically tested.
Historically, Sweden has been an early adopter of orphan drugs. In terms of market access, what sets Sweden apart is its value-based system of approval and…
At PCC, we meet all compliance standards, making us the market leader.
By using AI, big data, and other technologies we can explore how to translate the findings of NGS into usable information and knowledge at a much…
In the biomedical and healthcare related industries, patients are the center of everything. This industry is more about having as long-term plan to help improve the…
We are transforming our view from product-based - selling land, sea or air freight - to understanding what the customer needs are and looking at the…
At Bluefish we believe that price competitiveness is not the only key success factor in the generics business
